Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty

Bone

Volumn 33, Issue 1, 2003, Pages 144-149

  Yamaguchi, Katsuyuki ^a   Masuhara, Kensaku ^b   Yamasaki, Satoshi ^b   Nakai, Tsuyoshi ^c   Fuji, Takeshi ^b  

^a Kaizuka City Hospital   (Japan)

^b OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Bisphosphonates; Bone mineral density; Dual energy X ray absorptiometry; Etidronate; Stress shielding; Total hip arthroplasty

Indexed keywords

CALCIUM LACTATE; ETIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; OSTEOLYSIS; OSTEOPOROSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

EID: 0042206460     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00085-1     Document Type: Article

References (32)

1. Callaghan J.J., Albright J.C., Goetz D.D., Olejniczak J.P., Johnston R.C. Charnley total hip arthroplasty with cement. Minimum twenty-five-year follow-up. J Bone Joint Surg [Am]. 82:2000;487-497.
2. Engh C.A. Jr, Culpepper W.J. II, Engh C.A. Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg [Am]. 79:1997;177-184.
3. Xenos J.S., Callaghan J.J., Heekin R.D., Hopkinson W.J., Savory C.G., Moore M.S. The porous-coated anatomic total hip prosthesis, inserted without cement. A prospective study with a minimum of ten years of follow-up. J Bone Joint Surg [Am]. 81:1999;74-82.
4. Venesmaa P.K., Kröger H.P.J., Miettinen H.J.A., Jurvelin J.S., Suomalainen O.T., Alhava E.M. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty a prospective randomized study . J Bone Miner Res. 16:2001;2126-2131.
5. Matsui M., Nakata K., Masuhara K., Ohzono K., Sugano N., Ochi T. The metal-cancellous cementless Lübeck total hip arthroplasty. Five-to-nine-year results. J Bone Joint Surg [Br]. 80:1998;404-410.
6. Plötz W., Gradinger R., Rechl H., Ascherl R., Wicke-Wittenius S., Hipp E. Cementless prosthesis of the hip joint with "spongy metal" surface. A prospective study. Arch Orthop Trauma Surg. 111:1992;102-109.
7. Sugano N., Saito S., Takaoka K., Ohzono K., Masuhara K., Saito M., Ono K. Spongy metal Lübeck hip prostheses for osteoarthritis secondary to hip dysplasia. J Arthroplasty. 9:1994;253-262.
8. Gruen T.A., McNeice G.M., Amstutz H.C. "Modes of failure" of cemented stem-type femoral components. A radiographic analysis of loosening. Clin Orthop. 141:1979;17-27.
9. Engh C.A., Bobyn J.D. The influence of stem size and extent of porous coating on femoral bone resorption after primary cementless hip arthroplasty. Clin Orthop. 231:1988;7-28.
10. Engh C.A., McGovern T.F., Bobyn J.D., Harris W.H. A quantitative evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. J Bone Joint Surg [Am]. 74:1992;1009-1020.
11. Kiratli B.J., Checovich M.M., McBeath A.A., Wilson M.A., Heiner J.P. Measurement of bone mineral density by dual-energy X-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem. J Arthoplasty. 11:1996;184-193.
12. Maloney W.J., Sychterz C., Bragdon C., McGovern T., Jasty M., Engh C.A., Harris W.H. Skeletal response to well fixed femoral components inserted with and without cement. Clin Orthop. 333:1996;15-26.
13. Sychterz C.J., Engh C.A. The influence of clinical factors on periprosthetic bone remodeling. Clin Orthop. 322:1996;285-292.
14. Cohen B., Rushton N. Accuracy of DEXA measurement of bone mineral density after total hip arthroplasty. J Bone Joint Surg [Br]. 77:1995;479-483.
15. Wilson C.R., Fogelman I., Blake G.M., Rodin A. The effect of positioning on dual energy X-ray bone densitometry of the proximal femur. Bone Miner. 13:1991;69-76.
16. Kröger H., Miettinen H., Arnala I., Koski E., Rushton N., Suomalainen O. Evaluation of periprosthetic bone using dual-energy X-ray absorptiometry precision of the method and effect of operation on bone mineral density . J Bone Miner Res. 11:1996;1526-1530.
17. Kilgus D.J., Shimaoka E.E., Tipton J.S., Eberle R.W. Dual-energy X-ray absortiometry measurement of bone mineral density around porous-coated cementless femoral implants. Methods and preliminary results. J Bone Joint Surg [Br]. 75:1993;279-287.
18. Marchetti M.E., Steinberg G.G., Greene J.M., Jenis L.G., Baran D.T. A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty. J Bone Miner Res. 11:1996;1033-1039.
19. Storm T., Thamsborg G., Steiniche T., Genant H.K., Sorensen O.H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 322:1990;1265-1271.
20. Watts N.B., Harris S.T., Genant H.K., Wasnich R.D., Miller P.D., Jackson R.D., Licata A.A., Ross P., Woodson G.C. III, Yanover M.J., Mysiw W.J., Kohse L., Rao M.B., Steiger P., Richmond B., Chesnut C.H. III. Intermittent cyclical etidronate treatment of postmenopausal ostoporosis. N Engl J Med. 323:1990;73-79.
21. Harris S.T., Watts N.B., Jackson R.D., Genant H.K., Wasnich R.D., Ross P., Miller P.D., Licata A.A., Chesnut C.H. III. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis three years of blinded therapy followed by one year of open therapy . Am J Med. 95:1993;557-567.
22. Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., Nevitt M.C., Bauer D.C., Genant H.K., Haskell W.L., Marcus R., Ott S.M., Torner J.C., Quandt S.A., Reiss T.F., Ensrud K.E. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 348:1996;1535-1541.
23. Cummings S.R., Black D.M., Thompson D.E., Applegate W.B., Barrett-Connor E., Musliner T.A., Palermo L., Prineas R., Rubin S.M., Scott J.C., Vogt T., Wallace R., Yates A.J., LaCroix A.Z. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures results from the Fracture Intervention Trial . J Am Med Assoc. 280:1998;2077-2082.
24. Devogelaer J.P., Broll H., Correa-Rotter R., Cumming D.C., De Deuxchaisnes C.N., Geusens P., Hosking D., Jaeger P., Kaufman J.M., Leite M., Leon J., Liberman U., Menkes C.J., Meunier P.J., Reid I., Rodriguez J., Romanowicz A., Seeman E., Vermeulen A., Hirsch L.J., Lombardi A., Plezia K., Santora A.C., Yates A.J., Yuan W. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone. 18:1996;141-150.
25. Pols H.A.P., Felsenberg D., Hanley D.A., Stepan J., Munoz-Torres M., Wilkin T.J., Qin-sheng G., Galich A.M., Vandormael K., Yates A.J., Stych B. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass results of the FOSIT study . Osteopor Int. 9:1999;461-468.
26. Tucci J.R., Tonino R.P., Emkey R.D., Peverly C.A., Kher U., Santora A.C. II. Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med. 101:1996;488-501.
27. Cortet B., Bera-Louville A., Gauthier P., Gauthier A., Marchandise X., Delcambre B. Comparative efficacy and safety study of etidronate and alendronate in postmenopausl ostoporosis. Effect of adding hormone replacement therapy. Joint Bone Spine. 68:2001;410-415.
28. Massari L., Bagni B., Biscione R., Traina G.C. Periprosthetic bone density in uncemented femoral hip implants with proximal hydroxyapatite coating. Bull Hosp Joint Dis. 54:1996;206-210.
29. Nishii T., Sugano N., Masuhara K., Shibuya T., Ochi T., Tamura S. Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty. Clin Orthop. 339:1997;121-131.
30. Trevisan C., Bigoni M., Randelli G., Marinoni E.C., Peretti G., Ortolani S. Periprosthetic bone density around fully hydroxyapatite coated femoral stem. Clin Orthop. 340:1997;109-117.
31. Wixson R.L., Stulberg S.D., Van Flandern G.J., Puri L. Maintenance of proximal bone mass with an uncemented femoral stem analysis with dual-energy X-ray absorptiometry. J Arthroplasty. 12:1997;365-372.
32. Yamaguchi K., Masuhara K., Ohzono K., Sugano N., Nishii T., Ochi T. Evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. The influence of the extent of porous coating. J Bone Joint Surg [Am]. 82:2000;1426-1431.